Nashville、TNにおける心不全の臨床試験
Nashvilleとその周辺地域（約30マイル以内）の拠点で、心不全に関する19件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
ELEVATE-HFpEF Clinical Study
被験者募集中
- Saint Thomas Research Institute, Nashville
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
被験者募集中第3相
- Research Site, Nashville
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
被験者募集中第2相
- Vanderbilt University Medical Center, Nashville
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
被験者募集中第3相
- Vanderbilt University Medical Center, Nashville
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
被験者募集中第3相
- Research Site, Nashville
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
被験者募集中第3相
- Nashville, TN Investigative Site 10071, Nashville
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
被験者募集中
- St.Thomas Health, Nashville
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
被験者募集中観察研究
- Vanderbilt University, Nashville
Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
被験者募集中第1相
- Vanderbilt University Medical Center, Nashville
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
被験者募集中観察研究
- Nashville, Nashville
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
被験者募集中観察研究
- Tristar Centennial Medical Ctr, Nashville
- Saint Thomas Health, Nashville
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
被験者募集中第3相
- Tenax Investigational Site, Nashville
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
被験者募集中観察研究
- Vanderbilt University, Nashville
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
被験者募集中
- Vanderbilt, Nashville
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD
被験者募集中観察研究健康なボランティア歓迎
- Vanderbilt University Medical Center, Nashville
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
被験者募集中
- Centennial Medical Center, Nashville
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
被験者募集中
- Vanderbilt University Medical Center, Nashville
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
被験者募集中観察研究
- Vanderbilt University Medical Center, Nashville
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
被験者募集中観察研究
- Vanderbilt University Medical Center, Nashville
他の都市における心不全の試験
- New York City, NY51件の研究
- Boston, MA44件の研究
- Dallas, TX42件の研究
- Houston, TX36件の研究
- Cleveland, OH33件の研究
- Chicago, IL31件の研究
- Philadelphia, PA31件の研究
- San Francisco, CA29件の研究
- St. Louis, MO26件の研究
- Durham, NC26件の研究
- Atlanta, GA25件の研究
- Kansas City, MO25件の研究
Nashvilleにおける他の研究
- 非小細胞肺癌97件の研究
- 乳がん80件の研究
- 転移性癌70件の研究
- 大腸癌69件の研究
- がん（全種類）65件の研究
- 卵巣がん49件の研究
- 前立腺がん42件の研究
- 肺がん40件の研究
- 頭頸部扁平上皮癌39件の研究
- 膵臓がん39件の研究
- 子宮内膜がん38件の研究
- 悪性黒色腫33件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。